🔎 Trials Near Me

Početna › Psorijaza › Texas

Kliničke studije za Psorijaza u državi Texas

8 studija za Psorijaza traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

  • Precision Comprehensive Research, Colleyville
  • Rheumatology Associates of South Texas, San Antonio
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07801495

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • i još 2
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

  • Vanda Investigational Site, San Antonio
  • Vanda Investigational Site, Webster
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07362017

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  • Bellaire Dermatology Associates, Bellaire
  • Modern Research Associates, PLLC, Dallas
  • Center for Clinical Studies, Houston
  • i još 3
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06857942

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  • Texas Dermatology and Laser Specialists, San Antonio
  • Local Institution - 0280, Southlake
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06979453

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

  • Study Center, San Antonio
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 9. srp 2026. · NCT07489885

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  • M D Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 20. svi 2026. · NCT04751396

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

  • Clinical Investigations of Texas, Dallas
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 19. pro 2025. · NCT06982352

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.